Target intelligence / Profile preview

Epstein-Barr Virus Envelope Glycoprotein gL (gL)

Target
gL
Molecular classification
Viral glycoprotein, Envelope glycoprotein
01

Overview

Epstein-Barr virus (EBV) envelope glycoprotein gL is a conserved herpesvirus protein that forms a heterodimeric complex with glycoprotein H (gH). This gH/gL complex is essential for the fusion of the viral envelope with host cell membranes, enabling EBV entry into target cells such as B cells and epithelial cells. The gH/gL complex has a four-domain structure, with one end regulating activation of gB and the other participating directly in membrane fusion. It is required for efficient membrane fusion, directly binds to cellular receptors on epithelial cells, and interacts with other viral proteins such as gp42 during B cell infection. Because of its role in viral entry and the ability of neutralizing antibodies to target it, gL is an attractive target for antiviral drug and vaccine development.

02

Mechanism of action

Targeted by neutralizing antibodies to prevent viral entry.

03

Biological functions

Viral entryMembrane fusionReceptor binding
04

Disease associations

InfectionEBV-associated diseases

Beyond the preview

Go deeper on Epstein-Barr Virus Envelope Glycoprotein gL (gL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epstein-Barr Virus Envelope Glycoprotein gL (gL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call